Publications by authors named "Larry R Miller"

Claim this Profile
A
Acyclic, orally bioavailable ketone-based cathepsin K inhibitors.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, potent P2-P3 pyrrolidine derivatives of ketoamide-based cathepsin K inhibitors.
David G Barrett, John G Catalano, David N Deaton, Anne M Hassell, Stacey T Long, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?
Kim K Adkison, David G Barrett, David N Deaton, Robert T Gampe, Anne M Hassell, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles.
Francis X Tavares, David N Deaton, Aaron B Miller, Larry R Miller, Lois L Wright

Bioorg Med Chem Lett· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
P2-P3 conformationally constrained ketoamide-based inhibitors of cathepsin K.
David G Barrett, Virginia M Boncek, John G Catalano, David N Deaton, Anne M Hassell, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acyclic cyanamide-based inhibitors of cathepsin K.
David G Barrett, David N Deaton, Anne M Hassell, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A structural screening approach to ketoamide-based inhibitors of cathepsin K.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel and potent cyclic cyanamide-based cathepsin K inhibitors.
David N Deaton, Anne M Hassell, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.
David G Barrett, John G Catalano, David N Deaton, Anne M Hassell, Stacey T Long, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent and selective ketoamide-based inhibitors of cysteine protease, cathepsin K.
Francis X Tavares, David N Deaton, Aaron B Miller, Larry R Miller, Lois L Wright

J Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketoamide-based inhibitors of cysteine protease, cathepsin K: P3 modifications.
Francis X Tavares, David N Deaton, Larry R Miller, Lois L Wright

J Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the P2-P3 SAR of aldehyde cathepsin K inhibitors.
Eric E Boros, David N Deaton, Anne M Hassell, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Orally bioavailable small molecule ketoamide-based inhibitors of cathepsin K.
David G Barrett, John G Catalano, David N Deaton, Stacey T Long, Larry R Miller

Bioorg Med Chem Lett· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of small molecule ketoamide-based inhibitors of cathepsin K.
John G Catalano, David N Deaton, Stacey T Long, Robert B McFadyen, Larry R Miller

Bioorg Med Chem Lett· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of the P1 SAR of aldehyde cathepsin K inhibitors.
John G Catalano, David N Deaton, Eric S Furfine, Annie M Hassell, Robert B McFadyen, Aaron B Miller, Larry R Miller

Bioorg Med Chem Lett· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design of potent, selective, and orally bioavailable inhibitors of cysteine protease cathepsin k.
Francis X Tavares, Virginia Boncek, David N Deaton, Anne M Hassell, Stacey T Long, Aaron B Miller, Larry R Miller

J Med Chem· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis